Taff Jones

497 total citations
20 papers, 396 citations indexed

About

Taff Jones is a scholar working on Epidemiology, Immunology and Infectious Diseases. According to data from OpenAlex, Taff Jones has authored 20 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Immunology and 5 papers in Infectious Diseases. Recurrent topics in Taff Jones's work include Influenza Virus Research Studies (8 papers), Respiratory viral infections research (6 papers) and Immunotherapy and Immune Responses (5 papers). Taff Jones is often cited by papers focused on Influenza Virus Research Studies (8 papers), Respiratory viral infections research (6 papers) and Immunotherapy and Immune Responses (5 papers). Taff Jones collaborates with scholars based in Canada and United States. Taff Jones's co-authors include Raburn M. Mallory, Christopher S. Ambrose, David S. Burt, Xionghua Wu, George H. Lowell, Sonya Cyr, Martin Plante, Brian J. Ward, Filip Dubovsky and Li Shi and has published in prestigious journals such as PLoS ONE, Vaccine and The Pediatric Infectious Disease Journal.

In The Last Decade

Taff Jones

20 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Taff Jones Canada 11 260 155 152 60 35 20 396
Kathryn Edenborough Australia 10 209 0.8× 111 0.7× 159 1.0× 51 0.8× 31 0.9× 18 395
Lisa M. Esolen United States 8 433 1.7× 221 1.4× 174 1.1× 56 0.9× 20 0.6× 11 557
Karen E. Gooch United Kingdom 11 193 0.7× 300 1.9× 167 1.1× 94 1.6× 19 0.5× 18 456
Wieslawa Olszewska United Kingdom 12 432 1.7× 225 1.5× 151 1.0× 72 1.2× 41 1.2× 16 594
D. Tien Nguyen Netherlands 11 339 1.3× 123 0.8× 55 0.4× 39 0.7× 21 0.6× 14 415
Cathy Maes Belgium 10 326 1.3× 108 0.7× 128 0.8× 45 0.8× 42 1.2× 13 441
Fien De Boever Belgium 10 361 1.4× 179 1.2× 185 1.2× 74 1.2× 43 1.2× 17 491
Neil Formica Australia 10 296 1.1× 181 1.2× 87 0.6× 50 0.8× 11 0.3× 11 457
Pauline Maisonnasse France 12 86 0.3× 209 1.3× 140 0.9× 70 1.2× 13 0.4× 23 414
Tufária Mussá Mozambique 13 225 0.9× 161 1.0× 106 0.7× 61 1.0× 34 1.0× 28 421

Countries citing papers authored by Taff Jones

Since Specialization
Citations

This map shows the geographic impact of Taff Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taff Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taff Jones more than expected).

Fields of papers citing papers by Taff Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Taff Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taff Jones. The network helps show where Taff Jones may publish in the future.

Co-authorship network of co-authors of Taff Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Taff Jones. A scholar is included among the top collaborators of Taff Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Taff Jones. Taff Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ambrose, Christopher S., Xionghua Wu, Taff Jones, & Raburn M. Mallory. (2012). The role of nasal IgA in children vaccinated with live attenuated influenza vaccine. Vaccine. 30(48). 6794–6801. 90 indexed citations
2.
Daniëls, Tessa M. John, Eva Galiza, et al.. (2010). Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. The Pediatric Infectious Disease Journal. 29. 4 indexed citations
3.
Mallory, Raburn M., Elissa Malkin, Christopher S. Ambrose, et al.. (2010). Safety and Immunogenicity Following Administration of a Live, Attenuated Monovalent 2009 H1N1 Influenza Vaccine to Children and Adults in Two Randomized Controlled Trials. PLoS ONE. 5(10). e13755–e13755. 48 indexed citations
4.
Jones, Taff. (2010). Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection.. PubMed. 11(8). 964–70. 5 indexed citations
5.
Jones, Taff. (2009). IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection.. PubMed. 11(1). 90–6. 1 indexed citations
6.
Jones, Taff. (2009). GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection.. PubMed. 11(3). 337–45. 15 indexed citations
7.
Jones, Taff. (2008). IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.. PubMed. 10(4). 407–17. 11 indexed citations
11.
Jones, Taff, et al.. (2004). Protollin™: a novel adjuvant for intranasal vaccines. Vaccine. 22(27-28). 3691–3697. 37 indexed citations
12.
Jones, Taff. (2004). A chimeric live attenuated vaccine against Japanese encephalitis. Expert Review of Vaccines. 3(3). 243–248. 13 indexed citations
13.
Jones, Taff. (2003). Resiquimod 3M.. PubMed. 4(2). 214–8. 2 indexed citations
14.
15.
Jones, Taff. (2002). StaphVAX (Nabi).. PubMed. 3(1). 48–50. 3 indexed citations
16.
Jones, Taff, et al.. (2002). Remune. Immune Response.. PubMed. 3(3). 391–8. 1 indexed citations
17.
Jones, Taff. (2002). Hepagene (PowderJect).. PubMed. 3(7). 987–91. 2 indexed citations
18.
Jones, Taff. (2002). Varivax (Merck & Co).. PubMed. 3(1). 54–7. 4 indexed citations
20.
Jones, Taff & G. Tipton McKnight. (1985). Use of intravenous diazepam in patients on chronic hemodialysis undergoing surgery.. PubMed. 51(5). 291–2. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026